Catalytic Delivery NanoSubstrates (CDNS) for Highly Efficient Delivery of Biomolecules
CSEF · 2011 Pharmacology/ Toxicology
Overview
Objectives/Goals The delivery of biomolecules to rectify cells can potentially treat incurable diseases. Biomolecule delivery is performed with layer-by-layer deposition of biomolecules coated onto substrates. Targeted cells are then cultured on the substrates in order to induce biomolecule delivery. However, the pre-coating process prohibits continuous delivery of biomolecules. Furthermore, current approaches raise concerns pertaining to transfection performance, biocompatibility, and cell viability. In order to address these issues, Catalytic Delivery NanoSubstrates (CDNS) are engineered to efficiently deliver biomolecules to different types of cells. Additionally, to eliminate biomolecular pre-coating of substrates, CDNS use nanowires as substrates and improve delivery performance. Methods/Materials Transfection efficiency with CDNS was compared to that with two commercially available reagents, Lipofectamine 2000 and RGD-jet-PEI, at high and low DNA dosages. Enhanced green fluorescent protein (EGFP) was transfected into different cell lines. Additionally, cell viability after transfection was assessed for all transfection experiments. Results Transfection of EGFP using CDNS has the highest efficiency for all cell lines with both DNA dosages when compared to Lipofectamine 2000 and RGD-jet-PEI. In addition, cells transfected with CDNS exhibited high cell viability with both DNA dosages, whereas cells transfected with Lipofectamine 2000 and RGD-jet-PEI at high DNA dosage had lower cell viability. Conclusions/Discussion CDNS transfect biomolecules to different cells with high efficiency, compared to two commercially available reagents, Lipofectamine 2000 and RGD-jet-PEI. Cells transfected with CDNS had lower cytotoxicity as well. CDNS can potentially cure diseases by delivering biomolecules to cells for treatment and replacement. These substrates revolutionize in vivo and in vitro studies to treat cancer and deliver drugs.
Summary statement
This project develops Catalytic Delivery NanoSubstrates (CDNS) for not only highly efficient delivery of biomolecules into targeted cells but also high cell viability after transfection.
Help received
Used lab equipment at University of California, Los Angeles under the supervision and guidance of Dr. Tseng, Dr. Wang, and Dr. Liu.
Competition history
- CSEF 2011
Resources
Related projects
CSEF · 2018
Enhancing Gene Therapy through Targeted Delivery of CRIPSR/Cas9 in a Novel, Inexpensive Lipid Nanoparticle
ISEF · 2025
Novel Alternative Method to Improve the Safety and Targeting of Nanotherapeutics
CSEF · 2011
Optimization of Transfection Efficiency and Cell Viability in Various Cancer Cell Lines for Gene Therapy
CSEF · 2002
A Novel Cancer Killing Strategy: Direct Protein Delivery of Caspase-3
ISEF · 2018
Next Generation Intracellular Delivery: Optimization of Exosome Isolation and Novel Exosome-Mediated Delivery for Therapeutic Targeting of Cancer
ISEF · 2017
Chitosan Gelatin Microspheres: Using Fluorescein as an Indicator for the Delivery of Drugs into CEM, HeLa, and HEK 293 Cells
ISEF · 2024
NanoFusion: Revolutionizing CRISPR/Cas9 Delivery to MCF-7 Adenocarcinoma via Exosome-Liposome Synergy
ISEF · 2014
A Novel In-Clinic Patient- and Cancer- Tailored Targeted Drug Delivery System
Closest projects by meaning, across every fair and year in the corpus.
Browse more like this
Source: California Science & Engineering Fair public projects